Kukje Pharma Co., Ltd. (KRX:002720)
South Korea · Delayed Price · Currency is KRW 3,390.00
-45.00 (-1.31%)
At close: Jul 14, 2026
Kukje Pharma Market Cap
Kukje Pharma has a market cap or net worth of 69.03 billion as of July 14, 2026. Its market cap has decreased by -28.93% in one year.
Market Cap
69.03B
Enterprise Value
90.58B
Revenue
177.97B
Ranking
n/a
PE Ratio
11.64
Stock Price
3,390.00
Market Cap Chart
Since July 3, 2006, Kukje Pharma's market cap has increased from 29.64B to 69.03B, an increase of 132.88%. That is a compound annual growth rate of 4.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 69.03B | -21.16% |
| Dec 30, 2025 | 87.56B | -15.02% |
| Dec 30, 2024 | 103.03B | -14.06% |
| Dec 28, 2023 | 119.89B | 12.98% |
| Dec 29, 2022 | 106.12B | -5.98% |
| Dec 30, 2021 | 112.86B | -36.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyongbo Pharmaceutical | 120.73B |
| SAMSUNG PHARM. Co., LTD. | 117.18B |
| AptaBio Therapeutics | 114.90B |
| HANDOK | 101.33B |
| Jeil Pharma Holdings | 97.48B |
| HLB Pharmaceutical | 86.64B |
| Enzychem Lifesciences | 76.86B |
| CKD Bio | 72.52B |